3 studies on Cytokines mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
The low immunogenicity profile of AZD1402 (Elarekibep) is a critical finding, as it significantly reduces the risk of immune-mediated adverse events and potential loss of drug efficacy over time. This data provides st…
This research highlights the critical role of early monocyte modulation in influencing the trajectory of Alzheimer's disease (AD) pathology. The findings suggest that ARA 290 could represent a novel therapeutic strate…
The exploration of ARA 290, a non-hematopoietic erythropoietin analogue, holds significant promise as it targets a novel mechanism for glucose regulation, potentially offering a new therapeutic avenue beyond existing …